Considering the recent paradigm shift in healthcare, discuss this movement and its implications for competition.
How can changing the prescribed privileges of a provider affect competition? What benefits and challenges
exist as a result of expanding the scope of practice for a clinician? Considering this new entry into the market,
is this type of competition considered disruptive innovation? Why or why not?